Skip to main content
Erschienen in: Indian Journal of Surgical Oncology 1/2021

23.03.2021 | Case Report

Sebaceous Cell Carcinoma of the Lower Eyelid in an Elderly Male: a Rare Case Report and Review of Literature

verfasst von: Sachin S. Kadam, Tejaswini Kadam, Vishwanath Jigjinni, Sanjay M . H.

Erschienen in: Indian Journal of Surgical Oncology | Sonderheft 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Sebaceous cell carcinoma (SCC) arises from the sebaceous gland and it is considered as one of the aggressive dermatological malignancy. It may have an ocular as well as extra-ocular origin however, the most common site is the ocular region with the accountability of 34–59% cases [1]. The most common site of ocular origin is the upper eyelid due to the dense concentration of meibomian glands and involvement of the lower eyelid is a very rare presentation [2]. However simultaneous involvement of both eyelids has been found in about 1–6% of cases [3]. It is considered the third most common malignancy in the USA after basal cell carcinoma (BCC) followed by squamous cell carcinoma (SCC) which is contrary to Asian people in whom it is more common than BCC with accountability of around 28–60% of all ocular malignancies [4]. SCC is most commonly found in elderly patients with age range from 70 to 72 with no gender differentiation [5]. …
Literatur
1.
Zurück zum Zitat Tryggvason G, Bayon R, Pagedar NA (2012) Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management. Head Neck 34(12):1765–1768CrossRef Tryggvason G, Bayon R, Pagedar NA (2012) Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management. Head Neck 34(12):1765–1768CrossRef
2.
Zurück zum Zitat Mahipathy SR, Durairaj AR, Kothandaraman K, Rajamanohar VC, Prabakaran A (2016) Sebaceous gland carcinoma of the lower eyelid reconstructed with a composite flap: a case report. J Clin Diagn Res 10(6):PD16–PD18PubMedPubMedCentral Mahipathy SR, Durairaj AR, Kothandaraman K, Rajamanohar VC, Prabakaran A (2016) Sebaceous gland carcinoma of the lower eyelid reconstructed with a composite flap: a case report. J Clin Diagn Res 10(6):PD16–PD18PubMedPubMedCentral
3.
Zurück zum Zitat Bernardini FP (2006) Management of malignant and benign eyelid lesions. Curr Opin Ophthalmol 17(5):480–484CrossRef Bernardini FP (2006) Management of malignant and benign eyelid lesions. Curr Opin Ophthalmol 17(5):480–484CrossRef
4.
Zurück zum Zitat Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL (2005) Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol 50(2):103–122CrossRef Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL (2005) Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol 50(2):103–122CrossRef
5.
Zurück zum Zitat Dasgupta T, Wilson LD, Yu JB (2009) A retrospective review of 1,349 cases of sebaceous carcinoma. Cancer. 115(1):158–165CrossRef Dasgupta T, Wilson LD, Yu JB (2009) A retrospective review of 1,349 cases of sebaceous carcinoma. Cancer. 115(1):158–165CrossRef
6.
Zurück zum Zitat Pe’er J (2016) Pathology of eyelid tumors. Indian J Ophthalmol 64(3):177–190CrossRef Pe’er J (2016) Pathology of eyelid tumors. Indian J Ophthalmol 64(3):177–190CrossRef
7.
Zurück zum Zitat Stockl FA, Dolmetsch AM, Codere F, Burnier MN Jr (1995) Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome. Can J Ophthalmol 30(6):324–326PubMed Stockl FA, Dolmetsch AM, Codere F, Burnier MN Jr (1995) Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome. Can J Ophthalmol 30(6):324–326PubMed
8.
Zurück zum Zitat Gnepp DR (2012) My journey into the world of salivary gland sebaceous neoplasms. Head Neck Pathol 6:101–110CrossRef Gnepp DR (2012) My journey into the world of salivary gland sebaceous neoplasms. Head Neck Pathol 6:101–110CrossRef
9.
Zurück zum Zitat Sawyer AR, McGoldrick RB, Mackey S et al (2009) Should extraocular sebaceous carcinoma be investigated using sentinel node biopsy? Dermatol Surg 35:704–708CrossRef Sawyer AR, McGoldrick RB, Mackey S et al (2009) Should extraocular sebaceous carcinoma be investigated using sentinel node biopsy? Dermatol Surg 35:704–708CrossRef
10.
Zurück zum Zitat Husain A, Blumenschein G, Esmaeli B (2008) Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol 47:276–279CrossRef Husain A, Blumenschein G, Esmaeli B (2008) Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol 47:276–279CrossRef
11.
Zurück zum Zitat Plaza JA, Mackinnon A, Carrillo L, Prieto VG, Sangueza M, Suster S (2015) Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study. Am J Dermatopathol 37:809–821CrossRef Plaza JA, Mackinnon A, Carrillo L, Prieto VG, Sangueza M, Suster S (2015) Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study. Am J Dermatopathol 37:809–821CrossRef
12.
Zurück zum Zitat Mulay K, White VA, Shah SJ, Honavar SG (2014) Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Can J Ophthalmol 49:326–332CrossRef Mulay K, White VA, Shah SJ, Honavar SG (2014) Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Can J Ophthalmol 49:326–332CrossRef
13.
Zurück zum Zitat Hou JL, Killian JM, Baum CL, Otley CC, Roenigk RK, Arpey CJ, Weaver AL, Brewer JD (2014) Characteristics of sebaceous carcinoma and early outcomes of treatment using Mohs micrographic surgery versus wide local excision: an update of the Mayo Clinic experience over the past 2 decades. Dermatol Surg 40:241–246CrossRef Hou JL, Killian JM, Baum CL, Otley CC, Roenigk RK, Arpey CJ, Weaver AL, Brewer JD (2014) Characteristics of sebaceous carcinoma and early outcomes of treatment using Mohs micrographic surgery versus wide local excision: an update of the Mayo Clinic experience over the past 2 decades. Dermatol Surg 40:241–246CrossRef
14.
Zurück zum Zitat Hata M, Koike I, Maegawa J, Kaneko A, Odagiri K, Kasuya T, Minagawa Y, Kaizu H, Mukai Y, Inoue T (2012) Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function. Strahlenther Onkol 188:1102–1107CrossRef Hata M, Koike I, Maegawa J, Kaneko A, Odagiri K, Kasuya T, Minagawa Y, Kaizu H, Mukai Y, Inoue T (2012) Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function. Strahlenther Onkol 188:1102–1107CrossRef
15.
Zurück zum Zitat Russell HC, Chadha V, Lockington D, Kemp EG (2010) Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol 94:1316–1321CrossRef Russell HC, Chadha V, Lockington D, Kemp EG (2010) Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol 94:1316–1321CrossRef
16.
Zurück zum Zitat Khong JJ, Muecke J (2006) Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol 90:819–822CrossRef Khong JJ, Muecke J (2006) Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol 90:819–822CrossRef
17.
Zurück zum Zitat Deo SV, Shukla NK, Singh M et al (2012) Locally advanced sebaceous cell carcinoma (T3) of eyelid: incidence and pattern of nodal metastases and combined modality management approach. Orbit 31:150–154CrossRef Deo SV, Shukla NK, Singh M et al (2012) Locally advanced sebaceous cell carcinoma (T3) of eyelid: incidence and pattern of nodal metastases and combined modality management approach. Orbit 31:150–154CrossRef
18.
Zurück zum Zitat Jung YH, Woo IS, Kim MY, Han CW, Rha EY (2016) Palliative 5-fluorouracil and cisplatin chemotherapy in recurrent metastatic sebaceous carcinoma: case report and literature review. Asia Pac J Clin Oncol 12:e189CrossRef Jung YH, Woo IS, Kim MY, Han CW, Rha EY (2016) Palliative 5-fluorouracil and cisplatin chemotherapy in recurrent metastatic sebaceous carcinoma: case report and literature review. Asia Pac J Clin Oncol 12:e189CrossRef
19.
Zurück zum Zitat Thomas WW, Fritsch VA, Lentsch EJ (2013) Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck. Laryngoscope 123:2165–2169CrossRef Thomas WW, Fritsch VA, Lentsch EJ (2013) Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck. Laryngoscope 123:2165–2169CrossRef
20.
Zurück zum Zitat Park SJ, Wee WR, Lee JH, Kim MK (2009) Primary sebaceous carcinoma of the corneaoscleral limbus with pagetoid recurrence. Korean J Ophthalmol 23:104–107CrossRef Park SJ, Wee WR, Lee JH, Kim MK (2009) Primary sebaceous carcinoma of the corneaoscleral limbus with pagetoid recurrence. Korean J Ophthalmol 23:104–107CrossRef
Metadaten
Titel
Sebaceous Cell Carcinoma of the Lower Eyelid in an Elderly Male: a Rare Case Report and Review of Literature
verfasst von
Sachin S. Kadam
Tejaswini Kadam
Vishwanath Jigjinni
Sanjay M . H.
Publikationsdatum
23.03.2021
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe Sonderheft 1/2021
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-021-01305-9

Weitere Artikel der Sonderheft 1/2021

Indian Journal of Surgical Oncology 1/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.